Table 3. Adverse events according to diabetes status.

Results are expressed as n(%).

*: Statistically significant value.

^b: Adverse events were included if they were graded ≥3, judged as being possibly, probably, or definitely related to treatment. The only exception was for peripheral neuropathy which was considered if graded ≥2.

T2DM = type 2 diabetes mellitus

Adverse eventb	No T2DM (n = 133)	T2DM (n = 54)	P-value
Hematologic, n (%)
Neutropenia	8 (6.0)	3 (5.6)	>0.1
Anemia	4 (3.0)	0 (0.0)	0.33
Gastrointestinal, n (%)
Diarrhea	10 (7.5)	8 (14.8)	0.21
Vomiting	4 (3.0)	2 (3.7)	>0.1
Mucositis	2 (1.5)	0 (0.0)	>0.1
Anorexia	4 (3.0)	3 (5.6)	0.41
Neurologic, n (%)
Peripheral neuropathy	7 (5.3)	12 (22.2)	<0.01*
Others, n (%)
Hypertension	4 (3.0)	4 (7.4)	0.23
Pain	4 (3.0)	5 (9.3)	0.12
Asthenia	6 (4.5)	5 (9.3)	0.30